Overview

Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is an open label, balanced, randomized, two-treatment, two-period, two sequence, single dose, crossover, oral bioequivalence study.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Donepezil